We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 28 juni 2017

British Journal of Cancer - Table of Contents alert Volume 117 Issue 1

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 117, Issue 1 (1-155)
Published online 27 June 2017

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
We are pleased to announce that the Impact Factor* for the British Journal of Cancer is now 6.176 - an increase from 5.569 last year. The British Journal of Cancer is ranked 32 of 217 in the oncology category. The journal would like to thank all our authors, reviewers and readers for their continued support.

*2016 Journal Citation Reports (Clarivate Analytics, 2017) 

Submit your research >>>
 

Minireview

Top

Hallmarks of response to immune checkpoint blockade

Alexandria P Cogdill, Miles C Andrews and Jennifer A Wargo

Br J Cancer 2017 117: 1-7; advance online publication, May 18, 2017; 10.1038/bjc.2017.136

Abstract | Full Text

Clinical Studies

Top

Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group

F Koinis, S Agelaki, V Karavassilis, N Kentepozidis, E Samantas, S Peroukidis, P Katsaounis, E Hartabilas, I I Varthalitis, I Messaritakis, G Fountzilas, V Georgoulias and A Kotsakis

Br J Cancer 2017 117: 8-14; advance online publication, May 16, 2017; 10.1038/bjc.2017.137

Abstract | Full Text

Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer

Teresa E Brown, Merrilyn D Banks, Brett G M Hughes, Charles Y Lin, Lizbeth M Kenny and Judith D Bauer

Br J Cancer 2017 117: 15-24; advance online publication, May 23, 2017; 10.1038/bjc.2017.138

Abstract | Full Text

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach

Yukinori Kurokawa, Han-Kwang Yang, Haruhiko Cho, Min-Hee Ryu, Toru Masuzawa, Sook Ryun Park, Sohei Matsumoto, Hyuk-Joon Lee, Hiroshi Honda, Oh Kyoung Kwon, Takashi Ishikawa, Kyung Hee Lee, Kazuhito Nabeshima, Seong-Ho Kong, Toshio Shimokawa, Jeong-Hwan Yook, Yuichiro Doki, Seock-Ah Im, Seiichi Hirota, Seokyung Hahn, Toshirou Nishida and Yoon-Koo Kang

Br J Cancer 2017 117: 25-32; advance online publication, May 23, 2017; 10.1038/bjc.2017.144

Abstract | Full Text

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)

Glen J Weiss, Jordan Waypa, Lisa Blaydorn, Jessica Coats, Kayla McGahey, Ashish Sangal, Jiaxin Niu, Cynthia A Lynch, John H Farley and Vivek Khemka

Br J Cancer 2017 117: 33-40; advance online publication, June 6, 2017; 10.1038/bjc.2017.145

Abstract | Full Text

Translational Therapeutics

Top

High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice

Pavel Chernyavskiy, Elijah F Edmondson, Michael M Weil and Mark P Little

Br J Cancer 2017 117: 41-50; advance online publication, May 23, 2017; 10.1038/bjc.2017.141

Abstract | Full Text

Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice

Miika Martikainen, Janne Ruotsalainen, Johanna Tuomela, Pirkko Härkönen, Magnus Essand, Jari Heikkilä and Ari Hinkkanen

Br J Cancer 2017 117: 51-55; advance online publication, May 30, 2017; 10.1038/bjc.2017.151

Abstract | Full Text

Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis

Deeksha Pal, Suman Suman, Venkatesh Kolluru, Sophia Sears, Trinath P Das, Houda Alatassi, Murali K Ankem, Jonathan H Freedman and Chendil Damodaran

Br J Cancer 2017 117: 56-64; advance online publication, June 6, 2017; 10.1038/bjc.2017.143

Abstract | Full Text

Molecular Diagnostics

Top

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC

Carina Strell, Karin Jessica Norberg, Artur Mezheyeuski, Jonas Schnittert, Praneeth R Kuninty, Carlos Fernández Moro, Janna Paulsson, Nicolai Aagaard Schultz, Dan Calatayud, Johannes Matthias Löhr, Oliver Frings, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Jai Prakash, Julia Sidenius Johansen and Arne Östman

Br J Cancer 2017 117: 65-77; advance online publication, May 18, 2017; 10.1038/bjc.2017.140

Abstract | Full Text

MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1

Liang-liang Chen, Zhou-jing Zhang, Zhan-bo Yi and Jian-jun Li

Br J Cancer 2017 117: 78-88; advance online publication, June 1, 2017; 10.1038/bjc.2017.150

Abstract | Full Text

MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells

Yu-Xin Cui, Robyn Bradbury, Valentina Flamini, Bo Wu, Nicola Jordan and Wen G Jiang

Br J Cancer 2017 117: 89-101; advance online publication, June 1, 2017; 10.1038/bjc.2017.156

Abstract | Full Text

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

D Maciaczyk, D Picard, L Zhao, K Koch, D Herrera-Rios, G Li, V Marquardt, D Pauck, T Hoerbelt, W Zhang, D M Ouwens, M Remke, T Jiang, H J Steiger, J Maciaczyk and U D Kahlert

Br J Cancer 2017 117: 102-112; advance online publication, June 1, 2017; 10.1038/bjc.2017.157

Abstract | Full Text

Genetics & Genomics

Top

Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells

Jenni Nikkilä, Rahul Kumar, James Campbell, Inger Brandsma, Helen N Pemberton, Fredrik Wallberg, Kinga Nagy, Ildikó Scheer, Beata G Vertessy, Artur A Serebrenik, Valentina Monni, Reuben S Harris, Stephen J Pettitt, Alan Ashworth and Christopher J Lord

Br J Cancer 2017 117: 113-123; advance online publication, May 23, 2017; 10.1038/bjc.2017.133

Abstract | Full Text

A meta-analysis of CXCL12 expression for cancer prognosis

Harsh Samarendra, Keaton Jones, Tatjana Petrinic, Michael A Silva, Srikanth Reddy, Zahir Soonawalla and Alex Gordon-Weeks

Br J Cancer 2017 117: 124-135; advance online publication, May 23, 2017; 10.1038/bjc.2017.134

Abstract | Full Text

Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia

Sanjiban Chakrabarty, Vinay Koshy Varghese, Pranoy Sahu, Pradyumna Jayaram, Bhadravathi M Shivakumar, Cannanore Ganesh Pai and Kapaettu Satyamoorthy

Br J Cancer 2017 117: 136-143; advance online publication, May 18, 2017; 10.1038/bjc.2017.148

Abstract | Full Text

Epidemiology

Top

Frozen shoulder and risk of cancer: a population-based cohort study

Alma B Pedersen, Erzsébet Horváth-Puhó, Vera Ehrenstein, Mikael Rørth and Henrik T Sørensen

Br J Cancer 2017 117: 144-147; advance online publication, May 18, 2017; 10.1038/bjc.2017.146

Abstract | Full Text

Subcutaneous adiposity is an independent predictor of mortality in cancer patients

Maryam Ebadi, Lisa Martin, Sunita Ghosh, Catherine J Field, Richard Lehner, Vickie E Baracos and Vera C Mazurak

Br J Cancer 2017 117: 148-155; advance online publication, June 6, 2017; 10.1038/bjc.2017.149

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature